Page 5 - Explained News News Today

Retail price of the bulb across the country is in the Rs 250-350/kg range, which last year was around Rs 40/kg. Three months ago, the price was around Rs 150/kg.

This “process of conferring the ownership rights to the residents of unauthorised colonies and action as per the Development Control Norms for unauthorised colonies is under progress and will take time,” the Act says.

The Court pointed out that the provisions of the Constitution of India had been, step by step, between 1950 and 2019, extended to J&K and the ‘abrogation’ of Article 370 (a temporary provision) was the culmination of the process.

While there was never any doubt about J&K being an integral part of India, the Supreme Court's endorsement of the decisions of August 2019 has given ballast to New Delhi’s global diplomatic strategy on the dispute with Pakistan. Relations have been tense for four years, but a window for engagement could open after elections in both countries next year

Organ donations and transplants in exchange for money are forbidden in India in order to protect poor and vulnerable donors from potential exploitation.

After Russia's Ukraine invasion, Putin has seldom stepped out of his home country. So, how meaningful was his day-long visit to Riyadh and Abu Dhabhi this week?

After a decade of setbacks, New Delhi and Rome have worked hard to repair bilateral relations. Italy's changing views on China have added a strategic dimension to the ties, based on ancient links and a thriving trade partnership.

While it does sound reasonable to infer that faster GDP growth would help an incumbent government win re-election, is there any evidence that this is true? Similarly, do higher returns in the stock markets portend election victories for the incumbent?

While manufacturing has pushed up GDP growth beyond expectations, the agriculture and services sectors have seen a decline. What do this quarter's numbers really tell us about the economy?

The first therapy based on gene editing technology Crispr-Cas9 for sickle cell disease and thalassaemia has been approved in UK. The potential for India is revolutionary — however, cost is a huge deterrent currently